BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-203@pharmaconomics
DTSTAMP:20260707T015359Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:MNKD Phase 2 — Afrezza (estimated date)
DESCRIPTION:Phase 2 trial results for Afrezza in type 1 or type 2 diabetes are due ~ Dec 31\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/899460/000119312526243074/mnkd-20260527.htm\n\nTrack it: https://pharmaconomics.com/e/203
URL:https://pharmaconomics.com/e/203
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:MNKD catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR